Fact sheet: BB Medtech

Fund information

Fund name
BB Medtech B EUR
Fund company manager
Bellevue Asset Management
Fund type
SIB
Fund manager(s)
Stefan Blum
since 30/09/2009
Marcel Fritsch
since 30/09/2009
Fund objective
The Fund’s investment objective is to generate attractive and competitive capital growth in the long term. It is therefore particularly suited to investors with an investment horizon of at least 5 years who want to selectively diversify their portfolio with investments in the medtech sector and who are willing to accept the equity risk typical of this sector.
Benchmark
MSCI Healthcare Equip & Supp
Investment style
None
Investment method
Shares

Quick stats

1 Year return

5.31 %

1 Year rank in sector

20/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 214.1 m

FE Risk score

125

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    86.1%
  • Denmark
    4.2%
  • Netherlands
    3.2%
  • Japan
    2%
  • Others
    2%
  • Health Care
    81.1%
  • Others
    12.7%
  • Biotechnology/Medical
    5.6%
  • Money Market
    0.6%
  • US Equities
    86.1%
  • Danish Equities
    4.2%
  • Dutch Equities
    3.2%
  • International Equities
    2%
  • Japanese Equities
    2%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-3.63 %4.71 %5.31 %22.91 %96.62 %
Sector-4.11 %3.16 %6.44 %4.04 %87.67 %
Rank within sector11 / 3116 / 3120 / 304 / 2710 / 23
Quartile th2 nd3 rd3 rd1 st2 nd

Calendar performance

YTD-20182017201620152014
Fund1.59 %13.87 %6.5 %10.88 %35.42 %
Sector0.87 %14.94 %-9.92 %7.24 %28.08 %
Rank within sector14 / 3120 / 303 / 309 / 278 / 24
Quartile th2 nd3 rd1 st2 nd2 nd

Risk statistics

Alpha7.15
Beta0.68
Sharpe0.46
Volatility13.43
Tracking error10.08
Information ratio0.58
R-Squared0.6

Price movement

52 week high385.47
52 week low338.96
Current bid price0
Current offer price0
Current mid price365.06

Holdings by region

  • 86.1% USA
  • 4.2% Denmark
  • 3.2% Netherlands
  • 2% Japan
  • 2% Others
  • 1% Germany
  • 0.9% France
  • 0.6% Money Market

Holdings by sector

  • 81.1% Health Care
  • 12.7% Others
  • 5.6% Biotechnology/Medical
  • 0.6% Money Market

Holdings by asset type

  • 86.1% US Equities
  • 4.2% Danish Equities
  • 3.2% Dutch Equities
  • 2% International Equities
  • 2% Japanese Equities
  • 1% German Equities
  • 0.9% French Equities
  • 0.6% Money Market

Individual holdings

  • 9.3% ABBOTT LABORATORIES
  • 6.2% DANAHER CORP
  • 6% BOSTON SCIENTIFIC CORP
  • 5.7% STRYKER CORP
  • 5.6% MEDTRONIC PLC
  • 4.3% EDWARDS LIFESCIENCES CORP
  • 4.2% BAXTER INTERNATIONAL INC
  • 4.2% INTUITIVE SURGICAL INC
  • 4.1% BECTON DICKINSON & CO
  • 3.3% ZIMMER BIOMET HLDGS INC